We are pleased to announce that as of today, 15 October, the Second Draft Report focusing on the production of a Rapid Relative Effectiveness Assessment of new pharmaceuticals for the treatment of chronic hepatitis C by Work Package 5, Strand A has entered the public consultation phase.
We are pleased to announce that as of today, 14 October, 2015, the draft methodological guideline “Therapeutic medical devices”, produced within WP7 - Subgroup 3, has entered the public consultation phase.
We are pleased to announce that the 5th pilot rapid assessment of WP5 JA2 Strand B on “Transcatheter implantable devices for mitral valve repair in adults with chronic mitral valve regurgitation” is available.
Agendas of the EUnetHTA expert workshops in October, 2015, are now available. Reports from both workshops will be placed on the EUnetHTA public website after the meetings.
WP7 Subgroup 2 is pleased to announce the publication of its final deliverable - the Core protocol Pilot for Additional Evidence Generation (AEG).